Pennati M - Search Results

1

Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells.

Paduano F, Villa R, Pennati M, Folini M, Binda M, Daidone MG, Zaffaroni N. Paduano F, et al. Among authors: pennati m. Mol Cancer Ther. 2006 Jan;5(1):179-86. doi: 10.1158/1535-7163.MCT-05-0132. Mol Cancer Ther. 2006. PMID: 16432177

2

Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression.

Pennati M, Binda M, Colella G, Folini M, Citti L, Villa R, Daidone MG, Zaffaroni N. Pennati M, et al. J Invest Dermatol. 2003 Apr;120(4):648-54. doi: 10.1046/j.1523-1747.2003.12082.x. J Invest Dermatol. 2003. PMID: 12648230 Free article.

3

Inhibition of telomerase activity by geldanamycin and 17-allylamino, 17-demethoxygeldanamycin in human melanoma cells.

Villa R, Folini M, Porta CD, Valentini A, Pennati M, Daidone MG, Zaffaroni N. Villa R, et al. Among authors: pennati m. Carcinogenesis. 2003 May;24(5):851-9. doi: 10.1093/carcin/bgg028. Carcinogenesis. 2003. PMID: 12771028

4

Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.

Pennati M, Binda M, Colella G, Zoppe' M, Folini M, Vignati S, Valentini A, Citti L, De Cesare M, Pratesi G, Giacca M, Daidone MG, Zaffaroni N. Pennati M, et al. Oncogene. 2004 Jan 15;23(2):386-94. doi: 10.1038/sj.onc.1207071. Oncogene. 2004. PMID: 14724567

5

Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo.

Pennati M, Binda M, De Cesare M, Pratesi G, Folini M, Citti L, Daidone MG, Zunino F, Zaffaroni N. Pennati M, et al. Carcinogenesis. 2004 Jul;25(7):1129-36. doi: 10.1093/carcin/bgh107. Epub 2004 Feb 4. Carcinogenesis. 2004. PMID: 14764461

6

Survivin as a target for new anticancer interventions.

Zaffaroni N, Pennati M, Daidone MG. Zaffaroni N, et al. Among authors: pennati m. J Cell Mol Med. 2005 Apr-Jun;9(2):360-72. doi: 10.1111/j.1582-4934.2005.tb00361.x. J Cell Mol Med. 2005. PMID: 15963255 Free PMC article. Review.

7

Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation.

Pennati M, Campbell AJ, Curto M, Binda M, Cheng Y, Wang LZ, Curtin N, Golding BT, Griffin RJ, Hardcastle IR, Henderson A, Zaffaroni N, Newell DR. Pennati M, et al. Mol Cancer Ther. 2005 Sep;4(9):1328-37. doi: 10.1158/1535-7163.MCT-05-0022. Mol Cancer Ther. 2005. PMID: 16170024

8

Validation of telomerase and survivin as anticancer therapeutic targets using ribozymes and small-interfering RNAs.

Zaffaroni N, Pennati M, Folini M. Zaffaroni N, et al. Among authors: pennati m. Methods Mol Biol. 2007;361:239-63. doi: 10.1385/1-59745-208-4:239. Methods Mol Biol. 2007. PMID: 17172716 Review.

9

Targeting survivin in cancer therapy: fulfilled promises and open questions.

Pennati M, Folini M, Zaffaroni N. Pennati M, et al. Carcinogenesis. 2007 Jun;28(6):1133-9. doi: 10.1093/carcin/bgm047. Epub 2007 Mar 6. Carcinogenesis. 2007. PMID: 17341657 Review.

10

Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma.

Zaffaroni N, Costa A, Pennati M, De Marco C, Affini E, Madeo M, Erdas R, Cabras A, Kusamura S, Baratti D, Deraco M, Daidone MG. Zaffaroni N, et al. Among authors: pennati m. Cell Oncol. 2007;29(6):453-66. doi: 10.1155/2007/456839. Cell Oncol. 2007. PMID: 18032822 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters